Skip to main content
OpenTrials

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies
Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Completed

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

NCT03610724

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Johns Hopkins Oncology Center ORA Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Dept.of DFCI Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Completed

ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection

NCT06439433

Conditions
Cervical Intraepithelial Neoplasia Grade 2, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • Qilu Hospital of Shandong University Jinan, Shandong, China
  • The Obstetrics & Gynecology Hospital of Fudan University Shanghai, Shanghai Municipality, China
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

NCT04693637

Conditions
Adenoviridae Infections, Adenovirus Infection, BK Virus Infection, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Francisco Medical Center San Francisco, California, United States
  • Childrens National Medical Center Northwest Rectangle, District of Columbia, United States
View all 16 locations
View Trial Details
Completed

Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1

NCT04393753

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • UZ Leuven Leuven, Belgium
  • Bordeaux Hôpital Saint Andre Bordeaux, France
  • Hôpital Ambroise Paré - Boulogne-Billancourt Boulogne-Billancourt, France
  • CHU Nantes - Hotel Dieu Nantes, France
View all 22 locations
View Trial Details
Completed

Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC

NCT05253144

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • North Bristol NHS Trust Bristol, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • NHS Tayside Dundee, United Kingdom
View all 14 locations
View Trial Details

Related conditions